Video Latest - ecancer

War in Ukraine: Global cancer aid to support refugees

Dr Horia Vulpe , Dr Ruslan Baltaga

21 Jun 2022

Rucaparib effective as maintenance therapy following first-line platinum-based chemo in ovarian cancer

Dr Bradley Monk - University of Arizona College, Tucson, USA

21 Jun 2022

ASCO and WHO to collaborate on quality indicators for cancer facilities

Dr André Ilbawi - WHO Headquarters, Geneva, Switzerland

14 Jun 2022

Spotlight on global cancer control at ASCO 2022

Prof Eduardo Cazap - Editor-in-Chief, ecancer and SLACOM

10 Jun 2022

UICC announces global coalition to increase access to essential cancer medicines in low and lower middle-income countries

Dr Cary Adams - Chief Executive Officer, Union for International Cancer Control

9 Jun 2022

Safety and efficacy of olaparib plus metronomic cyclophosphamide and metformin in advanced/metastatic endometrial cancer

Prof Benoit You - Hospices Civils de Lyon, Lyon, France

14 Apr 2022

PETRA: Next generation PARP1-selective inhibitor AZD5305 in patients with BRCA1/2, PALB2 or RAD51C/D mutations

Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA

13 Apr 2022

OncoAlert and ecancer weekly round up for February 7th - 13th, 2022

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

17 Feb 2022

OncoAlert Colloquium Day 6: Gynaecological oncology, IGCS and ESO

Dr Don Dizon, Dr Allison Betof Warner, Dr Giancarlo Pruneri, Dr Pierfrancesco Franco & Dr Kathleen Schemeler

19 Jan 2022

Latest in advanced endometrial cancer

Prof Isabelle Ray-Coquard, Prof Christian Marth, Prof David Cibula, Prof Ignace Vergote

9 Dec 2021

OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

8 Dec 2021

The Lancet Commission on women and cancer

Prof Richard Sullivan - Kings College London, London, UK & Prof Ophira Ginsburg - International Agency for Research on Cancer, New York, USA

3 Dec 2021

Video